TCL Archive Pooled Analysis of Two LUX-Lung Trials Shows Prolonged Survival with Afatinib June 27, 2014
TCL Archive Phase III Trebananib Trial Fails OS Endpoint In Recurrent Platinum-Resistant Ovarian Cancer November 28, 2014
TCL Archive Eight Probable Minority CCOP Awardees Lister; NCI May Award As Many As 12, With 220 Payline June 1, 1990